Thomas N. Thompson

1.7k total citations · 1 hit paper
39 papers, 1.3k citations indexed

About

Thomas N. Thompson is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Thomas N. Thompson has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in Thomas N. Thompson's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (8 papers) and Computational Drug Discovery Methods (4 papers). Thomas N. Thompson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (8 papers) and Computational Drug Discovery Methods (4 papers). Thomas N. Thompson collaborates with scholars based in United States, Switzerland and United Kingdom. Thomas N. Thompson's co-authors include Miguel Muzzio, Izet M. Kapetanović, David L. McCormick, Zhihua Huang, Curtis D. Klaassen, Zoltán Gregus, John B. Watkins, J. B. Watkins, Kin‐Kai Hwang and James D. McChesney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas N. Thompson

32 papers receiving 1.2k citations

Hit Papers

Pharmacokinetics, oral bioavailability, and metabolic pro... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas N. Thompson United States 14 454 334 262 252 123 39 1.3k
Lesley A. Stanley United Kingdom 23 723 1.6× 452 1.4× 161 0.6× 367 1.5× 88 0.7× 41 1.7k
Chia‐Jui Weng Taiwan 26 1.0k 2.2× 413 1.2× 127 0.5× 292 1.2× 51 0.4× 36 2.1k
Rita Ghosh United States 29 1.2k 2.6× 150 0.4× 71 0.3× 330 1.3× 96 0.8× 76 2.1k
Morag McFadyen United Kingdom 20 813 1.8× 849 2.5× 36 0.1× 497 2.0× 62 0.5× 33 2.0k
Kathryn Roupe United States 12 293 0.6× 110 0.3× 196 0.7× 113 0.4× 74 0.6× 17 833
Renyi Wu United States 29 1.4k 3.0× 114 0.3× 67 0.3× 134 0.5× 86 0.7× 60 2.2k
Ni Ai United States 16 836 1.8× 233 0.7× 43 0.2× 233 0.9× 55 0.4× 32 1.7k
Irma Meijerman Netherlands 25 687 1.5× 808 2.4× 47 0.2× 667 2.6× 33 0.3× 52 2.1k
Norio Yamamoto Japan 25 779 1.7× 132 0.4× 50 0.2× 137 0.5× 234 1.9× 50 1.7k
Chongwoo Yu United States 12 248 0.5× 85 0.3× 317 1.2× 74 0.3× 119 1.0× 18 793

Countries citing papers authored by Thomas N. Thompson

Since Specialization
Citations

This map shows the geographic impact of Thomas N. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Thompson more than expected).

Fields of papers citing papers by Thomas N. Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Thompson. The network helps show where Thomas N. Thompson may publish in the future.

Co-authorship network of co-authors of Thomas N. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. Thompson. A scholar is included among the top collaborators of Thomas N. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. Thompson. Thomas N. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thompson, Thomas N.. (2016). Characterization of Remediation Methods for Heavy Hydrocarbon Contaminated Soil. OakTrust (Texas A&M University Libraries). 1 indexed citations
3.
Kapetanović, Izet M., Miguel Muzzio, David L. McCormick, et al.. (2012). Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats. Cancer Chemotherapy and Pharmacology. 69(5). 1301–1306. 5 indexed citations
4.
Chen, Linda, Mark Dreyer, Stephen B. Freedman, et al.. (2011). Discovery of a potent, orally bioavailable pyrimidine VLA-4 antagonist effective in a sheep asthma model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1741–1743. 4 indexed citations
5.
Kapetanović, Izet M., Miguel Muzzio, Zhihua Huang, Thomas N. Thompson, & David L. McCormick. (2010). Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemotherapy and Pharmacology. 68(3). 593–601. 506 indexed citations breakdown →
6.
Avery, Michael L., et al.. (2001). Evaluation of the BBMEC model for screening the CNS permeability of drugs. Journal of Pharmacological and Toxicological Methods. 45(1). 71–77. 15 indexed citations
7.
Thompson, Thomas N.. (2001). Optimization of metabolic stability as a goal of modern drug design. Medicinal Research Reviews. 21(5). 412–449. 98 indexed citations
8.
Thompson, Thomas N.. (2000). Early ADME in Support of Drug Discovery: The Role of Metabolic Stability Studies. Current Drug Metabolism. 1(3). 215–241. 62 indexed citations
9.
Brown, Paul W., et al.. (1997). Mass balance of14C-bismuth sucrose octasulfate in Sprague-Dawley rats: evidence for dissociation of bismuth from sucrose octasulfate. Biopharmaceutics & Drug Disposition. 18(9). 743–751. 1 indexed citations
10.
Thompson, Thomas N.. (1997). Experimental Models for Evaluating Enzyme Induction Potential of New Drug Candidates in Animals and Humans and a Strategy for Their Use. Advances in pharmacology. 43. 205–229. 2 indexed citations
11.
Janusz, Michael J., et al.. (1995). Pharmacological evaluation of selected, orally active, peptidyl inhibitors of human neutrophil elastase.. Journal of Pharmacology and Experimental Therapeutics. 275(3). 1233–1238. 2 indexed citations
12.
Kochak, Gregory M., et al.. (1988). Pentopril‐Cimetidine Interaction Caused by a Reduction in Hepatic Blood Flow. The Journal of Clinical Pharmacology. 28(3). 222–227. 10 indexed citations
13.
Thompson, Thomas N. & Curtis D. Klaassen. (1985). Hepatic presystemic elimination of diethylstilbestrol by rats and effect of pretreatment with inducers of UDP‐glucuronosyltransferase. Journal of Toxicology and Environmental Health. 16(3-4). 615–629. 1 indexed citations
14.
McChesney, James D. & Thomas N. Thompson. (1985). Stereochemistry of the reductive alkylation of .alpha.,.beta.-epoxy ketones. The Journal of Organic Chemistry. 50(19). 3473–3481. 29 indexed citations
15.
Thompson, Thomas N. & Curtis D. Klaassen. (1983). Disposition of metals after portal and systemic administration to rats. Toxicology and Applied Pharmacology. 68(3). 442–450. 3 indexed citations
16.
Gregus, Zoltán, John B. Watkins, Thomas N. Thompson, & Curtis D. Klaassen. (1982). Resistance of some phase II biotransformation pathways to hepatotoxins.. Journal of Pharmacology and Experimental Therapeutics. 222(2). 471–479. 35 indexed citations
17.
Watkins, John B., Zoltán Gregus, Thomas N. Thompson, & Curtis D. Klaassen. (1982). Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyltransferases. Toxicology and Applied Pharmacology. 64(3). 439–446. 89 indexed citations
18.
Thompson, Thomas N.. (1979). China's Nationalization of Foreign Firms: the Politics of Hostage Capitalism, 1949-57. 1979(6). 1. 3 indexed citations
19.
Blecher, Marc & Thomas N. Thompson. (1976). Looking for imperialism. Bulletin of Concerned Asian Scholars. 8(4). 49–54.
20.
Thompson, Thomas N.. (1971). Hearts: Of Surgeons and Transplants, Miracles and Disasters Along the Cardiac Frontier. Medical Entomology and Zoology. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026